Search for: "Merck and Co," Results 921 - 940 of 1,266
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
28 Feb 2011, 3:18 am by Bob Kraft
Bloomberg News reported, "The ruling is a victory for the four companies that supply vaccines for the US market -- Wyeth, GlaxoSmithKline Plc, Merck & Co. and Sanofi-Aventis SA. [read post]
2 Dec 2009, 4:31 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: http://duncanbucknell.com/subscribe/   Highlights this week included: World AIDS Day: Make it happen (Patent Baristas) (IP Watch) Venezuela to examine all pharmaceutical patents (IP tango)   General World AIDS Day: Make it happen (Patent Baristas) (IP Watch) Biodiversity negotiations need to allow for flexibility in business, industry says (IP Watch) Brazilian government tailors a bill on trade… [read post]
3 Jun 2010, 9:51 pm
Note: more useful materials for candidates will feature on this weblog in the next few days.Just referred to the Court of Justice for a preliminary ruling is Case C-125/10 Merck & Co Inc v Deutsches Patent- und Markenamt, in which the German Bundespatentgericht simply asks: "Can a supplementary protection certificate for medicinal products be granted if the period of time between the filing of the application for the basic patent and the date of first authorisation for… [read post]
15 Dec 2023, 12:03 pm by Seeger Weiss
With the resources and dedication to take on the world’s largest corporations, the firm has an impressive track record of victories against companies like Merck, Monsanto, and 3M—and a reputation for sticking with a case from beginning to end. [read post]
14 Jun 2012, 11:55 am by Stephen Jenei
Looking at which products will top the sales charts, Merck & Co.’s Type 2 diabetes therapy franchise, Januvia/Janumet, will reign with sales forecast showing a 10 percent compound annual growth rate between 2011 and 2018 to reach $9.7 billion in sales. [read post]
23 Feb 2009, 2:41 am
Merck & Co., 195 N.J. 51, 948 A.2d 587 (N.J. 2008)(plaintiffs could not maintain an action for medical monitoring in a pharmaceutical product liability action). [read post]
31 Mar 2022, 6:05 am by Searcy Law
These lawsuits have been filed against Johnson & Johnson, Janssen Pharmaceuticals, Bayer and Merck & Co., which are the companies that manufacture Avelox, Cipro and Levaquin. [read post]
27 Jan 2010, 3:00 am
Aurobindo Pharma Limited (Patentcircle) India/US: Indian pharma sector ‘fares well’ in US disputes (PatLit) India: The woes of the grassroot innovator in the agricultural sector (Spicy IP) South Africa: Biopiracy in Alice – Schwabe Pharamaceuticals wishes to patent method for extracting active ingredient in cough medicine from pelargonium roots (Afro-IP) UK: Okay to split costs where actions are joined, says Court of Appeal: Actavis UK Ltd v Eli Lilly & Co Ltd (PatLit)… [read post]
31 Mar 2022, 6:05 am by Searcy Law
These lawsuits have been filed against Johnson & Johnson, Janssen Pharmaceuticals, Bayer and Merck & Co., which are the companies that manufacture Avelox, Cipro and Levaquin. [read post]
31 Mar 2022, 6:05 am by Searcy Law
These lawsuits have been filed against Johnson & Johnson, Janssen Pharmaceuticals, Bayer and Merck & Co., which are the companies that manufacture Avelox, Cipro and Levaquin. [read post]
2 Sep 2009, 11:22 pm
Merck & Co., 949 A.2d 223, 271-76 (N.J. [read post]
11 Mar 2015, 9:15 am by Thomas Valenti
The international arm of US drugmaker Merck&Co. and Glenmark agreed to mediate and settle the patent infringement that has been filed by the former MNC against the latter generic drugmaker for launching generic copies of two of its diabetic drugs Januvia and Janumet in the Indian market in 2013. [read post]